Journals / Türk Kardiyoloji Derneği Arşivi / 2017 / Cilt: 45 - Sayı: 5

Survey of Risk Factor Management (SURF) data of Turkey: Cardiovascular risk factor control ratios in 15 different types of healthcare centers

SURF (SUrvey of Risk Factor Management) çalışması Türkiye değerlendirmesi: Farklı basamaklardan 15 sağlık merkezinin verilerinde kardiyovasküler risk faktörleri kontrol oranları

Pages
398–407
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Low-density lipoprotein cholesterol was below 70 mg/dL in 12.2% of the patients using statins.Conclusion: According to the data obtained, among Turkish CHD patients, the control rate of cardiovascular risk factors is low, and implementation of the recommendations regarding lifestyle modification and medication use for secondary prevention in the current guidelines are insufficient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the adherence to recommendations for secondary prevention and the achievement of treatment targets for the control of risk factors in patients with established coronary heart disease (CHD) who were followed-up at various healthcare facilities in Turkey.Methods: According to the protocol of the international Survey of Risk Factor Management study, questionnaire forms were completed and demographic, anthropometric, and laboratory data of CHD patients who were followed-up at a total of 15 selected primary, secondary, and tertiary healthcare centers were recorded.Results: Among a total of 724 CHD patients (69.8% male; mean age: 63.3±10.7 years) included in the study, 18.4% were current smokers, only 19.1% had normal body mass index, and 22.1% had waist circumference below the limit of abdominal obesity.
📊
Key Findings & Data:Physical activity was insufficient in 53% of the patients, 47.3% had low high-density lipoprotein cholesterol value, 46% had triglyceride level above 150 mg/dL, and 67% had glycated hemoglobin value of 6.5% or above.
💡
Conclusion & Impact:Low-density lipoprotein cholesterol was below 70 mg/dL in 12.2% of the patients using statins.Conclusion: According to the data obtained, among Turkish CHD patients, the control rate of cardiovascular risk factors is low, and implementation of the recommendations regarding lifestyle modification and medication use for secondary prevention in the current guidelines are insufficient.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to evaluate the adherence to recommendations for secondary prevention and the achievement of treatment targets for the control of risk factors in patients with established coronary heart disease (CHD) who were followed-up at various healthcare facilities in Turkey.Methods: According to the protocol of the international Survey of Risk Factor Management study, questionnaire forms were completed and demographic, anthropometric, and laboratory data of CHD patients who were followed-up at a total of 15 selected primary, secondary, and tertiary healthcare centers were recorded.Results: Among a total of 724 CHD patients (69.8% male; mean age: 63.3±10.7 years) included in the study, 18.4% were current smokers, only 19.1% had normal body mass index, and 22.1% had waist circumference below the limit of abdominal obesity. Physical activity was insufficient in 53% of the patients, 47.3% had low high-density lipoprotein cholesterol value, 46% had triglyceride level above 150 mg/dL, and 67% had glycated hemoglobin value of 6.5% or above. Of all the patients, 88.1% were using antiplatelet drugs, 71.4% were using beta-blockers, 55.7% were using statins, and 41.9% were using angiotensin-converting enzyme inhibitors/angiotensin receptor blockers. Blood pressure was under control in 56.7% of the hypertensive patients using antihypertensive drugs, and the proportion of diabetic patients who reached glycemic control targets using antidiabetic drugs was 35.9%. Low-density lipoprotein cholesterol was below 70 mg/dL in 12.2% of the patients using statins.Conclusion: According to the data obtained, among Turkish CHD patients, the control rate of cardiovascular risk factors is low, and implementation of the recommendations regarding lifestyle modification and medication use for secondary prevention in the current guidelines are insufficient.

Özet

Amaç: Bu çalışmanın amacı, ülkemizdeki değişik basamaklardaki sağlık merkezlerinde izlenmekte olan koroner kalp hastalığı (KKH) olan hastalarda sekonder koruma önerilerine uyum ve risk faktörleri kontrolü için önerilen hedef değerlere ulaşım oranlarının değerlendirilmesi.Yöntemler: Birinci, ikinci ve üçüncü basamaklardan seçilmiş toplam 15 merkezde izlenmekte olan KKH'li hastaların uluslararası SURF (Survey of Risk Factor management) protokolüne uygun olarak anket formları doldurularak, demografik, antropometrik ve laboratuvar verileri kaydedildi.Bulgular: Çalışmaya alınan toplam 724 KKH'li hastanın (%69.8 erkek, ortalama yaş: 63.3±10.7) %18.4'ü halen sigara kullanmakta, sadece %19.1'inin beden kütle indeksi normal sınırlarda ve %22.1'inin bel çevresi abdominal obezite sınırının altında idi. Hastaların %53'ünün fiziksel aktivite düzeyleri yetersiz, %47.3'ünün yüksek yoğunluklu lipoprotein kolestrol düzeyi düşük, %46'sının trigliserit düzeyi 150 mg/dL'nin üstünde, %67'sinin HbA1c düzeyi %6.5 ve üzerindeydi. Hastaların %88.1'i antiagregan, %71.4'ü beta bloker, %55.7'si statin ve %41.9'u anjiyotensin dönüştürücü enzim inhibitörü/anjiyotensin reseptör blokeri kullanmaktaydı. Hipertansiyonu olan ve antihipertansif ilaç kullanan hasta grubunun %56.7'sinde kan basıncı kontrol altında, diyabet tanısı olan ve antidiyabetik ilaç kullanan hasta grubunda glisemik kontrol hedeflerine ulaşma oranı %35.9 idi. Statin kullanan hasta grubunun %12.2'sinde düşük yoğunluklu lipoprotein kolestrol 70 mg/dL'nin altındaydı.Sonuç: Ülkemizdeki çeşitli basamaklardaki sağlık merkezlerinden elde edilen verilere göre, KKH'li hastalarda kardiyovasküler risk faktörleri kontrol oranı düşük, güncel kılavuzların önerdiği yaşam tarzı değişiklikleri ve ilaç kullanımı yetersizdir.

🔖

Cite This Article

BEKTAŞ, O., TOKGÖZOĞLU, L., TEKİN, M., BALCI, M. K., OĞUZ, A., TEMİZHAN, A., IYİGÜN, Ö., ÇELİK, S., ALTUNOĞLU, E. G., ASLAN, G., TANRIVERDİ, H. P., YAVUZ, S., ERCAN, S., MERİÇLİLER, Ö. S., ÇAKIR, İ. B., KARA, A. (2022). Survey of Risk Factor Management (SURF) data of Turkey: Cardiovascular risk factor control ratios in 15 different types of healthcare centers. Türk Kardiyoloji Derneği Arşivi, Cilt: 45 - Sayı: 5, 398–407. https://ajindex.com/articles/632383

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation 2014;129:1483¬- 92
  2. Clark AM, Hartling L, Vandermeer B, McAlister FA. Metaanalysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005;143:659-72
  3. McAlister FA, Lawson FM, Teo KK, Armstrong PW. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 2001;323:957-62
  4. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635-701
  5. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-37
  6. Kotseva K, Wood D, De Bacquer D, De Backer G, Rydén L, Jennings C, et al; EUROASPIRE Investigators. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol 2016;23:636-48
  7. Cooney M, Reiner Z, Sheu W, Ryden L, Sutter Jd, De Bacquer D, et al; SURF investigators; Prevention, Epidemiology and Population Science Section of the European Association for Cardiovascular Prevention and Rehabilitation. SURF - SUrvey of Risk Factor management: first report of an international audit. Eur J Prev Cardiol 2014;21:813-22
  8. Zhao M, Cooney MT, Klipstein-Grobusch K, Vaartjes I, De Bacquer D, De Sutter J, et al. Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries. Eur J Prev Cardiol 2016;23:1202-10
  9. Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006;6:300
  10. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, R